Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials

Lancet

Volumn 355, Issue 9219, 2000, Pages 1981-1987

  Grosskurth, Heiner ^a   Gray, Ronald ^b   Hayes, Richard ^a   Mabey, David ^a   Wawer, Maria ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Joseph L Mailman Sch of Pub Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; GENITAL HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; UGANDA; VAGINITIS; VIRUS LOAD;

EID: 0034600451     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02336-9     Document Type: Review

References (37)

1. An overview of selected curable sexually transmitted diseases. WHO/GPA/STD 95.1. 1995;WHO, Geneva.
2. World development report 1993: investing in health. 1993;Oxford University Press, New York.
3. Mertens T.E., Hayes R.J., Smith P.G. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS. 4:1990;57-65.
4. Stamm W.E., Handsfield H.H., Rompalo A.M., Ashley R.L., Roberts P.L., Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 260:1988;1429-1433.
5. Cameron D.W., Simonsen J.N., D'Costa L.J.et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. ii:1989;403-407.
6. Plummer F.A., Simonsen J.N., Cameron D.W.et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis. 163:1991;233-239.
7. Laga M., Manoka A., Kivuvu M.et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women. results from a cohort study AIDS. 7:1993;95-102.
8. Cohen M.S., Hoffman I.F., Royce R.A.et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis. implications for prevention of sexual transmission of HIV-1 Lancet. 349:1997;1868-1873.
9. Ghys P.D., Fransen K., Diallo M.O.et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS. 11:1997;F85-F93.
10. Mostad S.B., Overbaugh J., DeVange D.M.et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 350:1997;922-927.
11. Pepin J., Plummer F.A., Brunham R.C. The interaction of HIV infection and other sexually transmitted diseases. an opportunity for intervention AIDS. 3:1989;3-9.
12. Management of patients with sexually transmitted diseases. Report of a WHO Study Group. World Health Organization Technical Report Series, no 810. 1991;WHO, Geneva.
13. Laga M., Alary M., Nzila N.et al. Condom promotion, sexually-transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 344:1994;246-248.
14. Laga M. Review of evidence for STD as cofactors in HIV transmission and framework for analysis. Presented at a WHO/UNAIDS consultation, Oct 14-16, 1998. STD interventions for preventing HIV: what is the evidence? 1998;WHO/UNAIDS, Geneva.
15. Steen R., Vuylsteke B., De Coito T.et al. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sex Transm Dis. 27:2000;1-8.
16. Hayes R., Mosha F., Nicoll A.et al. A community trial of the impact of improved STD treatment on the HIV epidemic in rural Tanzania: 1. Design. AIDS. 9:1995;916-926.
17. Grosskurth H., Mosha F., Todd J.et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania. randomised controlled trial Lancet. 346:1995;530-536.
18. Grosskurth H., Mosha F., Todd J.et al. A community trial of the impact of improved STD treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS. 9:1995;927-934.
19. Hayes R., Grosskurth H., ka-Gina G. Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet. 346:1995;1159-1160.
20. Mayaud P., Mosha F., Todd J.et al. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania. results of a randomised controlled trial AIDS. 11:1997;1873-1880.
21. Wawer M.J., Gray R.H., Sewankambo N.K.et al. A randomised, community-based trial of intense sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 12:1998;1211-1225.
22. Wawer M.J., Sewankambo N., Serwadda D.et al. Control of sexually transmitted diseases for AIDS prevention in Uganda. a randomised community trial Lancet. 353:1999;525-535.
23. Todd J., Balira R., Grosskurth H.et al. HIV associated adult mortality in a rural Tanzanian population. AIDS. 11:1997;801-807.
24. Robinson N.J., Mulder D.W., Auvert B., Hayes R. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population. simulation model estimates Int J Epidemiol. 26:1997;180-189.
25. Quinn T.C., Wawer M.J., Sewankambo N.K.et al. Viral load and heterosexual transmission of human immune deficiency virus type 1. N Engl J Med. 342:2000;921-929.
26. Obasi A., Mosha F., Quigley M.et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania. J Infect Dis. 179:1999;16-24.
27. Ballard R. The effect of antiviral treatment of HSV-2 lesions on the cervico-vaginal shedding of HIV. Presented at a WHO/UNAIDS consultation, Oct 14-16, 1998. STD interventions for preventing HIV: what is the evidence? 1998;WHO/UNAIDS, Geneva.
28. Plummer F.A. HIV and STD incidence in a sex worker cohort: 1985-1997. Presented at a WHO/UNAIDS consultation, Oct 14-16, 1998. STD interventions for preventing HIV: what is the evidence? 1998;WHO/UNAIDS, Geneva.
29. Chen C.Y., Ballard R.C., Beck-Sague C.M.et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa. The herpetic connection. Sex Transm Dis. 27:2000;21-29.
30. Sewankambo N., Gray R.H., Wawer M.J., et al H.I.V. 1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 350:1997;546-550.
31. Attawell K., Grosskurth H. From knowledge to practice: STD control and HIV prevention. 1999;Office for Official Publications of the European Communities, Brussels.
32. Fleming D., Wasserheit J. From epidemiological synergy to public health policy and practice. the contribution of other sexually transmitted diseases to sexual transmission of HIV infection Sex Transm Infect. 75:1999;3-17.
33. Gray R.H., Wawer M.J., Sewankambo N.K.et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. AIDS. 13:1999;2113-2123.
34. Orroth K., Gavyole A., Todd J.et al. Syndromic STD treatment reduces the proportion of incident HIV infections attributable to STD in rural Tanzania. AIDS. 2000;. (in press).
35. Korenromp E.L., Van Vliet C., Grosskurth H.et al. Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS. 14:2000;573-593.
36. Brugha R., Zwi A.B. Sexually transmitted disease control in developing countries. the challenge of involving the private sector Sex Transm Infect. 74:1999;283-285.
37. Hayes R., Wawer M., Gray R., Whitworth J., Grosskurth H., Mabey D. HIV/STD Trials Workshop Group. Randomised trials of STD treatment for HIV prevention: report of an international workshop. Genitourin Med. 73:1997;432-443.